Rachel Wightman

1.3k total citations · 1 hit paper
48 papers, 828 citations indexed

About

Rachel Wightman is a scholar working on Public Health, Environmental and Occupational Health, Emergency Medicine and Pharmacology. According to data from OpenAlex, Rachel Wightman has authored 48 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Public Health, Environmental and Occupational Health, 13 papers in Emergency Medicine and 11 papers in Pharmacology. Recurrent topics in Rachel Wightman's work include Opioid Use Disorder Treatment (29 papers), Poisoning and overdose treatments (12 papers) and Forensic Toxicology and Drug Analysis (9 papers). Rachel Wightman is often cited by papers focused on Opioid Use Disorder Treatment (29 papers), Poisoning and overdose treatments (12 papers) and Forensic Toxicology and Drug Analysis (9 papers). Rachel Wightman collaborates with scholars based in United States, Austria and Guatemala. Rachel Wightman's co-authors include Lewis S. Nelson, Elizabeth A. Samuels, Jeanmarie Perrone, Ian Portelli, Caroline Wunsch, Jeanmarie Perrone, Seth Clark, Shruti Patel, Amit Mahajan and D. Kyle Hogarth and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Rachel Wightman

44 papers receiving 813 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Xylazine Adulteration of the Heroin–Fentanyl Drug Supply

2023 61 citations Lewis S. Nelson, Jeanmarie Perrone et al. profile →

Peers

Rachel Wightman

PHEOH

EPIDE

APM

PHARM

John Halpin United States

J. Elise Bailey United States

James P. Trinidad United States

Michael Gilbert United States

Malcolm Dobbin Australia

Jennifer L. Pilgrim Australia

Lauren J. Tanz United States

Howard A. Heit United States

S. Geoff Severtson United States

Rebecca McDonald United Kingdom

John Halpin United States

Rachel Wightman

538 ×1.1

PHEOH

212 ×1.0

EPIDE

220 ×1.4

APM

169 ×1.1

68 ×0.6

PHARM

Citations per year, relative to Rachel Wightman Rachel Wightman (= 1×) peers John Halpin

Countries citing papers authored by Rachel Wightman

Since Specialization

Citations

This map shows the geographic impact of Rachel Wightman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Wightman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Wightman more than expected).

Fields of papers citing papers by Rachel Wightman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Wightman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Wightman. The network helps show where Rachel Wightman may publish in the future.

Co-authorship network of co-authors of Rachel Wightman

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Wightman. A scholar is included among the top collaborators of Rachel Wightman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Wightman. Rachel Wightman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spadaro, Anthony, et al.. (2025). Characterization of Reddit Posts About Xylazine-Associated Wounds: Qualitative Study. JMIR Dermatology. 8. e70329–e70329. 1 indexed citations

Krieger, Maxwell S., et al.. (2024). Patients presenting to the ED with nonfatal drug overdose: Self-reported history of overdose and naloxone use. The American Journal of Emergency Medicine. 82. 21–25.

Wightman, Rachel, et al.. (2024). Substances in Counterfeit Prescription Pills Seized by Law Enforcement, 2017-2022. JAMA. 331(21). 1860–1860. 7 indexed citations

Chambers, Laura C., et al.. (2024). Randomised clinical trial of a 16 mg vs 24 mg maintenance daily dose of buprenorphine to increase retention in treatment among people with an opioid use disorder in Rhode Island: study protocol paper. BMJ Open. 14(11). e085888–e085888. 1 indexed citations

Wightman, Rachel, et al.. (2024). Buprenorphine prescribing and treatment accessibility in response to regulation changes due to the COVID-19 public health emergency. Journal of Substance Use and Addiction Treatment. 162. 209382–209382. 1 indexed citations

Wightman, Rachel, et al.. (2023). Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department. Academic Emergency Medicine. 31(5). 463–470. 4 indexed citations

Wightman, Rachel, Jane Metrik, Yu Li, et al.. (2023). Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis Syndrome. Annals of Emergency Medicine. 82(2). 121–130. 4 indexed citations

Wightman, Rachel, et al.. (2023). An analysis of cannabinoid hyperemesis syndrome Reddit posts and themes. Clinical Toxicology. 61(4). 283–289. 2 indexed citations

Chambers, Laura C., Benjamin D. Hallowell, Andrew R. Zullo, et al.. (2023). Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl. JAMA Network Open. 6(9). e2334540–e2334540. 60 indexed citations

10.

Collins, Alexandra B., Francesca L. Beaudoin, Jane Metrik, & Rachel Wightman. (2023). “I still partly think this is bullshit”: A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting. Drug and Alcohol Dependence. 246. 109853–109853. 9 indexed citations

11.

Pozo, Brandon del, Danielle N. Atkins, Barbara Andraka‐Christou, et al.. (2023). Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021. SHILAP Revista de lepidopterología. 6. 100131–100131. 7 indexed citations

12.

Collins, Alexandra B., et al.. (2023). Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island. International Journal of Drug Policy. 118. 104118–104118. 21 indexed citations

13.

Wunsch, Caroline, Rachel Wightman, Brendan Jacka, et al.. (2022). Thirty-day Treatment Continuation After Audio-only Buprenorphine Telehealth Initiation. Journal of Addiction Medicine. 17(2). 206–209. 7 indexed citations

14.

Green, Traci C., Rebecca E. Olson, Earth Erowid, et al.. (2022). Implementation and Uptake of the Massachusetts Drug Supply Data Stream: A Statewide Public Health-Public Safety Partnership Drug Checking Program. Journal of Public Health Management and Practice. 28(Supplement 6). S347–S354. 29 indexed citations

15.

Jacka, Brendan, Hannah N. Ziobrowski, Janette Baird, et al.. (2021). Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist program. Academic Emergency Medicine. 29(3). 294–307. 9 indexed citations

16.

Wightman, Rachel, Jeanmarie Perrone, Benjamin D. Hallowell, et al.. (2021). Toxicological and pharmacologic sex differences in unintentional or undetermined opioid overdose death. Drug and Alcohol Dependence. 227. 108994–108994. 10 indexed citations

17.

Wightman, Rachel, et al.. (2020). A Case Report of Isopropanol Ingestion During the SARS-CoV-2 Pandemic. Journal of Addiction Medicine. 14(5). e264–e266.

18.

Collins, Alexandra B., et al.. (2020). The Impact of COVID-19 on Service Provision for Emergency Department Patients Post-Opioid Overdose: A Field Report. Journal of Addiction Medicine. 15(5). 432–434. 7 indexed citations

19.

Wightman, Rachel, Lewis S. Nelson, Joshua D. Lee, Lindsay Fox, & Silas W. Smith. (2018). Severe opioid withdrawal precipitated by Vivitrol®. The American Journal of Emergency Medicine. 36(6). 1128.e1–1128.e2. 13 indexed citations

20.

Wightman, Rachel, Jeanmarie Perrone, Ian Portelli, & Lewis S. Nelson. (2012). Likeability and Abuse Liability of Commonly Prescribed Opioids. Journal of Medical Toxicology. 8(4). 335–340. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact